Clinical Trial Update: Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating topotecan in combination with gefitinib (Iressa) for ovarian, peritoneal, or fallopian tube cancers has completed phase 1/2 with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Neoplasms

Drugs mentioned

• Gefitinib (Gefitinib)
• Topotecan (topotecan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer, Peritoneal Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-07